Cargando…
pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
Cancer immunotherapy has gained significant momentum from recent clinical successes of checkpoint blockade inhibition. Massively parallel sequence analysis suggests a connection between mutational load and response to this class of therapy. Methods to identify which tumor-specific mutant peptides (n...
Autores principales: | Hundal, Jasreet, Carreno, Beatriz M., Petti, Allegra A., Linette, Gerald P., Griffith, Obi L., Mardis, Elaine R., Griffith, Malachi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733280/ https://www.ncbi.nlm.nih.gov/pubmed/26825632 http://dx.doi.org/10.1186/s13073-016-0264-5 |
Ejemplares similares
-
Cancer Immunogenomics: Computational Neoantigen Identification and Vaccine Design
por: Hundal, Jasreet, et al.
Publicado: (2017) -
Accounting for proximal variants improves neoantigen prediction
por: Hundal, Jasreet, et al.
Publicado: (2018) -
Best practices for bioinformatic characterization of neoantigens for clinical utility
por: Richters, Megan M., et al.
Publicado: (2019) -
Neoantigens and genome instability: impact on immunogenomic phenotypes and immunotherapy response
por: Mardis, Elaine R.
Publicado: (2019) -
Influence of PVAc/PVA Hydrolysis on Additive Surface Activity
por: Squillace, Ophélie, et al.
Publicado: (2020)